Pre-Clinical Applications - MolecuLight US

Research Category:Species Detected/Biofilm, Pre-Clinical Applications

Detection of bacterial fluorescence from in vivo wound biofilms using a point‐of‐care fluorescence imaging device

International Wound Journal, 09 Feb 2021

Download Publication

Research Category:Species Detected/Biofilm, Pre-Clinical Applications

In vitro detection of porphyrin-producing wound bacteria with real-time fluorescence imaging

FUTURE MICROBIOLOGY, 26 Feb 2020

Download Publication

Research Category:Pre-Clinical Applications, Detection of Bacterial Burden

Autofluorescence imaging device for real-time detection and tracking of pathogenic bacteria in a mouse skin wound model: preclinical feasibility studies

Journal of Biomedical Optics, 2014, 19(8). doi: 10.1117/1.JBO.19.8.085002.

Download Publication

Find out how to make a difference in wound care

MolecuLight Headquarters

425 University Avenue
Suite 700
Toronto, ON M5G 1T6
Canada

US Address
MolecuLight Corp.
2403 Sidney Street,
Suite 209
Pittsburgh, PA 15203

T. 1-877-818-4360
North American Toll Free:
1-877-818-4360
F.+1 647-362-4730
E: info@moleculight.com

MolecuLight is SOC ll^®
Type l Accredited:

MolecuLight awarded
Premier’s Technology
Breakthrough Designation

MolecuLight i:X
is designated as a:

MolecuLight included
in ISWCAP Consensus
Guidelines:

MolecuLight is a proud
corporate member of:

Global

USA

©2024
The MolecuLight® i:X and MolecuLightDX™ Imaging Devices are approved by Health Canada for sale in Canada and has CE marking for sale in the European Union.
The MolecuLight™ i:X and DX Imaging Devices have received FDA clearance.